HealthFlex
×
  • Home
  • Immunology Book
  • Lab Tests
    • Hematology
    • Fluid analysis
    • CSF
    • Urine Analysis
    • Chemical pathology
    • Blood banking
    • Fungi
    • General pathology
    • Immune system
    • Microbiology
    • Parasitology
    • Pathology
    • Tumor marker
    • Virology
    • Cytology
  • Lectures
    • Bacteriology
    • Liver
    • Lymph node
    • Mycology
    • Virology
  • Blog
    • Economics and technical
    • Fitness health
    • Mental health
    • Nutrition
    • Travel
    • Preventive health
    • Nature and photos
    • General topic
  • Medical Dictionary
  • About Us
  • Contact

Syphilis – Part 2 – V.D.R.L (Venereal disease research laboratory test)

September 27, 2020Lab TestsMicrobiology

Sample

  • This is done on the serum of the patient.

Purpose of the test (Indication)

  • This is a screening test for syphilis.

Pathophysiology

  1. Syphilis is a venereal disease.
  2. The causative agent for syphilis is Treponema pallidum, which is a spirochete.
  3. The spirochete is 8 to 15 µm in length, gram-negative organisms.
Treponema Pallidum is like a corkscrew shape

Treponema Pallidum is like a corkscrew shape

  1. Spirochaetes are microaerophilic but this organism cannot be cultured in vitro.
  2. This is motile with rotation around its long axis as well as flexion and extension laterally.
  3. T.pallidum survives in the patient with syphilis and it has no other habitat.
  4. The untreated disease has three stages and these may last for many years.
    1. Primary stage.
    2. Secondary stage.
    3. Tertiary stage.
Syphilis various stages of the disease

Syphilis various stages of the disease

  1. This test will detect antibodies against Treponema Pallidum, and these antibodies appear in 4 to 6 weeks.
  2. VDRL is a nontreponemal test that detects reagin and antibodies that act against cardiolipin as an antigen.
  3. During primary and tertiary syphilis the test may be falsely negative.
  4. Another nontreponemal test is Rapid plasma reagin (RPR).
  5. VDRL is a screening test.
    1. VDRL may show the negative result is late syphilis.
  6. Other treponemal antibody tests are:
    1. TP-PA ( particle agglutination T.pallidum ).
    2. FTA-ABS ( fluorescent treponemal antibody test.

VDRL test principle

  1. This test is performed using a cardiolipin-lecithin cholesterol antigen.
  2. Heat-inactivated serum from the patient is used.
VDRL test principle

VDRL test principle

  1. This test can also be done on the CSF as well.
  2. Advantage:
    1. This is inexpensive.
    2. This is reproducible.
  3. Disadvantage:
    1. Not 100% specific for syphilis.
    2. Confirm by FTA-ABS or TP-MHA test.
    3. Run positive and negative control

NORMAL

  • A negative test means that no antibody to syphilis has been detected.
  • This screening test is most likely positive for Secondary and latent syphilis.

Negative VDRL

  1. No syphilis.
  2. Done when antibodies are still not developed.
  3. In the late or inactive phase.
  4. The patient has an immune deficiency.
  5. Lab error.

False-positive test

  1. HIV
  2. Lyme disease
  3. certain types of pneumonia
  4. Malaria
  5. Systemic lupus erythematosus.

Possible References Used
Go Back to Lab Tests

Add Comment Cancel


  • Lab Tests
    • Blood banking
    • Chemical pathology
    • CSF
    • Cytology
    • Fluid analysis
    • Fungi
    • General pathology
    • Hematology
    • Immune system
    • Microbiology
    • Parasitology
    • Pathology
    • Tumor marker
    • Urine Analysis
    • Virology

About Us

Labpedia.net is non-profit health information resource. All informations are useful for doctors, lab technicians, nurses, and paramedical staff. All the tests include details about the sampling, normal values, precautions, pathophysiology, and interpretation.

[email protected]

Quick Links

  • Blog
  • About Us
  • Contact
  • Disclaimer

Our Team

Professor Dr. Riaz Ahmad Bhutta

Dr. Naheed Afroz Syed

Dr. Asad Ahmad, M.D.

Dr. Shehpar Khan, M.D.

Copyright © 2014 - 2023. All Rights Reserved.
Web development by Farhan Ahmad.